Benzinga's Top Ratings Upgrades, Downgrades For August 28, 2023

Author: Benzinga Insights | August 28, 2023 11:00am

Upgrades

According to B of A Securities, the prior rating for Futu Holdings Ltd (NASDAQ:FUTU) was changed from Underperform to Buy. In the second quarter, Futu Hldgs showed an EPS of $1.09, compared to $0.61 from the year-ago quarter. The stock has a 52-week-high of $72.20 and a 52-week-low of $28.01. At the end of the last trading period, Futu Hldgs closed at $51.06.

According to Truist Securities, the prior rating for Apartment Income REIT Corp (NYSE:AIRC) was changed from Hold to Buy. In the second quarter, Apartment Income REIT showed an EPS of $0.58, compared to $0.66 from the year-ago quarter. At the moment, the stock has a 52-week-high of $43.70 and a 52-week-low of $32.51. Apartment Income REIT closed at $33.49 at the end of the last trading period.

According to Truist Securities, the prior rating for UDR Inc (NYSE:UDR) was changed from Hold to Buy. UDR earned $0.61 in the second quarter, compared to $0.57 in the year-ago quarter. The current stock performance of UDR shows a 52-week-high of $48.31 and a 52-week-low of $37.18. Moreover, at the end of the last trading period, the closing price was at $39.17.

For MACOM Technology Solutions Holdings Inc (NASDAQ:MTSI), Benchmark upgraded the previous rating of Hold to Buy. For the third quarter, MACOM Technology Solns had an EPS of $0.54, compared to year-ago quarter EPS of $0.73. The current stock performance of MACOM Technology Solns shows a 52-week-high of $81.54 and a 52-week-low of $48.53. Moreover, at the end of the last trading period, the closing price was at $80.04.

For Emerson Electric Co (NYSE:EMR), Argus Research upgraded the previous rating of Hold to Buy. Emerson Electric earned $1.29 in the third quarter, compared to $1.38 in the year-ago quarter. At the moment, the stock has a 52-week-high of $99.65 and a 52-week-low of $72.42. Emerson Electric closed at $97.64 at the end of the last trading period.

For Church & Dwight Co Inc (NYSE:CHD), Truist Securities upgraded the previous rating of Hold to Buy. For the second quarter, Church & Dwight Co had an EPS of $0.92, compared to year-ago quarter EPS of $0.76. At the moment, the stock has a 52-week-high of $100.52 and a 52-week-low of $70.16. Church & Dwight Co closed at $93.30 at the end of the last trading period.

For AppFolio Inc (NASDAQ:APPF), William Blair upgraded the previous rating of Market Perform to Outperform. For the second quarter, AppFolio had an EPS of $0.23, compared to year-ago quarter EPS of $0.03. The stock has a 52-week-high of $195.90 and a 52-week-low of $93.04. At the end of the last trading period, AppFolio closed at $183.82.

According to HC Wainwright & Co., the prior rating for Akebia Therapeutics Inc (NASDAQ:AKBA) was changed from Neutral to Buy. In the second quarter, Akebia Therapeutics showed an EPS of $0.06, compared to $0.15 from the year-ago quarter. The stock has a 52-week-high of $1.84 and a 52-week-low of $0.24. At the end of the last trading period, Akebia Therapeutics closed at $1.15.

Wells Fargo upgraded the previous rating for UGI Corp (NYSE:UGI) from Equal-Weight to Overweight. In the third quarter, UGI showed an EPS of $0.00, compared to $0.06 from the year-ago quarter. At the moment, the stock has a 52-week-high of $43.19 and a 52-week-low of $22.45. UGI closed at $22.71 at the end of the last trading period.

BTIG upgraded the previous rating for Zimmer Biomet Holdings Inc (NYSE:ZBH) from Neutral to Buy. In the second quarter, Zimmer Biomet Holdings showed an EPS of $1.82, compared to $1.82 from the year-ago quarter. The current stock performance of Zimmer Biomet Holdings shows a 52-week-high of $149.25 and a 52-week-low of $102.60. Moreover, at the end of the last trading period, the closing price was at $115.24.

According to Piper Sandler, the prior rating for Mister Car Wash Inc (NYSE:MCW) was changed from Neutral to Overweight. In the second quarter, Mister Car Wash showed an EPS of $0.08, compared to $0.11 from the year-ago quarter. At the moment, the stock has a 52-week-high of $11.14 and a 52-week-low of $6.43. Mister Car Wash closed at $6.89 at the end of the last trading period.

See all analyst ratings upgrades.

Downgrades

HC Wainwright & Co. downgraded the previous rating for NovoCure Ltd (NASDAQ:NVCR) from Buy to Neutral. For the second quarter, NovoCure had an EPS of $0.54, compared to year-ago quarter EPS of $0.23. At the moment, the stock has a 52-week-high of $120.03 and a 52-week-low of $26.68. NovoCure closed at $29.77 at the end of the last trading period.

Alliance Global Partners downgraded the previous rating for AgileThought Inc (NASDAQ:AGIL) from Buy to Sell. For the second quarter, AgileThought had an EPS of $0.13, compared to year-ago quarter EPS of $0.04. The current stock performance of AgileThought shows a 52-week-high of $4.80 and a 52-week-low of $0.20. Moreover, at the end of the last trading period, the closing price was at $0.26.

For VMware Inc (NYSE:VMW), Monness, Crespi, Hardt downgraded the previous rating of Buy to Neutral. For the first quarter, VMware had an EPS of $1.49, compared to year-ago quarter EPS of $1.28. The stock has a 52-week-high of $170.00 and a 52-week-low of $104.03. At the end of the last trading period, VMware closed at $162.55.

Truist Securities downgraded the previous rating for Essex Property Trust Inc (NYSE:ESS) from Buy to Hold. In the second quarter, Essex Property Trust showed an EPS of $3.77, compared to $3.68 from the year-ago quarter. The current stock performance of Essex Property Trust shows a 52-week-high of $284.02 and a 52-week-low of $195.03. Moreover, at the end of the last trading period, the closing price was at $237.24.

For Energizer Holdings Inc (NYSE:ENR), Truist Securities downgraded the previous rating of Buy to Hold. For the third quarter, Energizer Hldgs had an EPS of $0.54, compared to year-ago quarter EPS of $0.77. At the moment, the stock has a 52-week-high of $37.89 and a 52-week-low of $24.81. Energizer Hldgs closed at $34.56 at the end of the last trading period.

Wells Fargo downgraded the previous rating for Atmos Energy Corp (NYSE:ATO) from Overweight to Equal-Weight. In the third quarter, Atmos Energy showed an EPS of $0.94, compared to $0.92 from the year-ago quarter. The current stock performance of Atmos Energy shows a 52-week-high of $125.28 and a 52-week-low of $97.83. Moreover, at the end of the last trading period, the closing price was at $117.70.

For Upwork Inc (NASDAQ:UPWK), BTIG downgraded the previous rating of Buy to Neutral. Upwork earned $0.10 in the second quarter, compared to $0.04 in the year-ago quarter. At the moment, the stock has a 52-week-high of $18.57 and a 52-week-low of $6.56. Upwork closed at $14.75 at the end of the last trading period.

HC Wainwright & Co. downgraded the previous rating for Timber Pharmaceuticals Inc (AMEX:TMBR) from Buy to Neutral. Timber Pharmaceuticals earned $1.32 in the second quarter, compared to $7.50 in the year-ago quarter. At the moment, the stock has a 52-week-high of $8.72 and a 52-week-low of $1.21. Timber Pharmaceuticals closed at $3.03 at the end of the last trading period.

Jefferies downgraded the previous rating for Denbury Inc (NYSE:DEN) from Buy to Hold. For the second quarter, Denbury had an EPS of $1.06, compared to year-ago quarter EPS of $1.69. The stock has a 52-week-high of $104.05 and a 52-week-low of $73.24. At the end of the last trading period, Denbury closed at $89.25.

JP Morgan downgraded the previous rating for Lyell Immunopharma Inc (NASDAQ:LYEL) from Overweight to Neutral. Lyell Immunopharma earned $0.04 in the second quarter, compared to $0.04 in the year-ago quarter. The current stock performance of Lyell Immunopharma shows a 52-week-high of $8.74 and a 52-week-low of $1.77. Moreover, at the end of the last trading period, the closing price was at $2.29.

For CrowdStrike Holdings Inc (NASDAQ:CRWD), Morgan Stanley downgraded the previous rating of Overweight to Equal-Weight. CrowdStrike Holdings earned $0.57 in the first quarter, compared to $0.31 in the year-ago quarter. At the moment, the stock has a 52-week-high of $203.59 and a 52-week-low of $92.25. CrowdStrike Holdings closed at $149.58 at the end of the last trading period.

For Century Therapeutics Inc (NASDAQ:IPSC), JP Morgan downgraded the previous rating of Overweight to Neutral. Century Therapeutics earned $0.56 in the second quarter, compared to $0.54 in the year-ago quarter. At the moment, the stock has a 52-week-high of $11.95 and a 52-week-low of $2.28. Century Therapeutics closed at $2.39 at the end of the last trading period.

For L3Harris Technologies Inc (NYSE:LHX), Bernstein downgraded the previous rating of Outperform to Market Perform. For the second quarter, L3Harris Technologies had an EPS of $2.97, compared to year-ago quarter EPS of $6.38. The current stock performance of L3Harris Technologies shows a 52-week-high of $255.02 and a 52-week-low of $174.55. Moreover, at the end of the last trading period, the closing price was at $178.46.

See all analyst ratings downgrades.

Initiations

With a Buy rating, UBS initiated coverage on 89bio Inc (NASDAQ:ETNB). The price target seems to have been set at $36.00 for 89bio. For the second quarter, 89bio had an EPS of $0.52, compared to year-ago quarter EPS of $1.23. At the moment, the stock has a 52-week-high of $22.93 and a 52-week-low of $4.18. 89bio closed at $16.52 at the end of the last trading period.

UBS initiated coverage on Akero Therapeutics Inc (NASDAQ:AKRO) with a Buy rating. The price target for Akero Therapeutics is set to $83.00. For the second quarter, Akero Therapeutics had an EPS of $0.60, compared to year-ago quarter EPS of $0.77. The stock has a 52-week-high of $58.38 and a 52-week-low of $10.49. At the end of the last trading period, Akero Therapeutics closed at $47.97.

With a Buy rating, Craig-Hallum initiated coverage on Xeris Biopharma Holdings Inc (NASDAQ:XERS). The price target seems to have been set at $4.50 for Xeris Biopharma Holdings. For the second quarter, Xeris Biopharma Holdings had an EPS of $0.14, compared to year-ago quarter EPS of $0.19. The current stock performance of Xeris Biopharma Holdings shows a 52-week-high of $3.07 and a 52-week-low of $0.97. Moreover, at the end of the last trading period, the closing price was at $2.15.

For Bio-Techne Corp (NASDAQ:TECH), William Blair initiated coverage, by setting the current rating at Outperform. Bio-Techne earned $0.55 in the fourth quarter, compared to $0.51 in the year-ago quarter. The stock has a 52-week-high of $90.34 and a 52-week-low of $68.30. At the end of the last trading period, Bio-Techne closed at $80.16.

With a Buy rating, ThinkEquity initiated coverage on Alliance Entertainment Holding Corp (NASDAQ:AENT). The price target seems to have been set at $6.00 for Alliance Entertainment. The stock has a 52-week-high of $4.20 and a 52-week-low of $1.71. At the end of the last trading period, Alliance Entertainment closed at $2.20.

Cantor Fitzgerald initiated coverage on NextGen Healthcare Inc (NASDAQ:NXGN) with an Overweight rating. The price target for NextGen Healthcare is set to $21.00. In the first quarter, NextGen Healthcare showed an EPS of $0.24, compared to $0.16 from the year-ago quarter. The stock has a 52-week-high of $21.92 and a 52-week-low of $15.23. At the end of the last trading period, NextGen Healthcare closed at $17.95.

With a Buy rating, Seaport Global initiated coverage on Liberty Live Group (NASDAQ:LLYVA). The price target seems to have been set at $56.00 for Liberty Live. The stock has a 52-week-high of $37.00 and a 52-week-low of $32.07. At the end of the last trading period, Liberty Live closed at $33.16.

With a Neutral rating, Citigroup initiated coverage on Cricut Inc (NASDAQ:CRCT). The price target seems to have been set at $10.50 for Cricut. Cricut earned $0.07 in the second quarter, compared to $0.06 in the year-ago quarter. At the moment, the stock has a 52-week-high of $17.89 and a 52-week-low of $6.04. Cricut closed at $9.27 at the end of the last trading period.

HC Wainwright & Co. initiated coverage on Reneo Pharmaceuticals Inc (NASDAQ:RPHM) with a Buy rating. The price target for Reneo Pharmaceuticals is set to $30.00. For the second quarter, Reneo Pharmaceuticals had an EPS of $0.65, compared to year-ago quarter EPS of $0.50. The stock has a 52-week-high of $11.29 and a 52-week-low of $1.79. At the end of the last trading period, Reneo Pharmaceuticals closed at $6.25.

Canaccord Genuity initiated coverage on Surf Air Mobility Inc (NYSE:SRFM) with a Buy rating. The price target for Surf Air Mobility is set to $3.00. The stock has a 52-week-high of $5.00 and a 52-week-low of $1.10. At the end of the last trading period, Surf Air Mobility closed at $1.34.

Goldman Sachs initiated coverage on Corporacion Inmobiliaria Vesta SAB de CV (NYSE:VTMX) with a Neutral rating. The price target for Corporacion Inmobiliaria is set to $36.00. For the second quarter, Corporacion Inmobiliaria had an EPS of $0.01, compared to year-ago quarter EPS of $0.02. The current stock performance of Corporacion Inmobiliaria shows a 52-week-high of $38.62 and a 52-week-low of $31.50. Moreover, at the end of the last trading period, the closing price was at $37.79.

With an Outperform rating, Wolfe Research initiated coverage on Workiva Inc (NYSE:WK). The price target seems to have been set at $120.00 for Workiva. In the second quarter, Workiva showed an EPS of $0.02, compared to $0.17 from the year-ago quarter. At the moment, the stock has a 52-week-high of $112.21 and a 52-week-low of $60.33. Workiva closed at $100.06 at the end of the last trading period.

RBC Capital initiated coverage on Tetra Tech Inc (NASDAQ:TTEK) with an Outperform rating. The price target for Tetra Tech is set to $181.00. Tetra Tech earned $1.29 in the third quarter, compared to $1.08 in the year-ago quarter. The current stock performance of Tetra Tech shows a 52-week-high of $173.27 and a 52-week-low of $122.86. Moreover, at the end of the last trading period, the closing price was at $157.24.

With a Buy rating, Laidlaw & Co. initiated coverage on SILO Pharma Inc (NASDAQ:SILO). The price target seems to have been set at $10.00 for SILO Pharma. The current stock performance of SILO Pharma shows a 52-week-high of $12.22 and a 52-week-low of $1.71. Moreover, at the end of the last trading period, the closing price was at $1.94.

With a Market Outperform rating, JMP Securities initiated coverage on Pagaya Technologies Ltd (NASDAQ:PGY). The price target seems to have been set at $2.75 for Pagaya Techs. Pagaya Techs earned $0.00 in the second quarter, compared to $0.00 in the year-ago quarter. The current stock performance of Pagaya Techs shows a 52-week-high of $14.82 and a 52-week-low of $0.57. Moreover, at the end of the last trading period, the closing price was at $1.95.

See all analyst ratings initiations.

Posted In: AENT AGIL AIRC AKBA AKRO APPF ATO CHD CRCT CRWD DEN EMR ENR ESS ETNB FUTU IPSC LHX LLYVA LYEL